> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Determines Regulatory Review Period for Baxter’s Obizur
- URL: https://www.fdaweb.com/fda-determines-regulatory-review-period-for-baxters-obizur/
- Published: 2017-10-23T12:00:00.000Z
- Updated: 2026-09-14T22:57:35.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139930

*Federal Register* notice: FDA has determined for patent extension purposes that the regulatory review period for Baxter’s Obizur is 4,216 days, and of this time 3,883 days occurred during the testing phase and 333 days occurred during the approval phase. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-23/pdf/2017-22898.pdf?ref=fdaweb.com).